AstraZeneca PLC (LON:0A4J)

AstraZeneca Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 28, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	200,042	162,287	164,292	173,826	134,436	96,139
Market Cap Growth	11.87%	-1.22%	-5.49%	29.30%	39.84%	-3.67%
Enterprise Value	218,315	182,260	184,338	197,853	154,735	109,746
Last Close Price	62.61	51.28	50.59	52.49	39.56	32.13
PE Ratio	28.61	28.88	35.14	63.70	1625.31	41.07
PS Ratio	4.63	3.76	4.57	4.72	4.87	4.93
PB Ratio	5.85	4.97	5.34	5.65	4.63	8.39
P/FCF Ratio	21.24	20.45	23.29	24.03	37.36	34.20
P/OCF Ratio	17.76	17.13	20.23	21.35	30.53	27.35
EV/Sales Ratio	5.05	4.22	5.13	5.38	5.60	5.63
EV/EBITDA Ratio	14.14	12.99	16.51	17.35	31.27	21.44
EV/EBIT Ratio	18.46	17.65	24.34	27.05	72.32	34.29
EV/FCF Ratio	23.18	22.96	26.14	27.35	43.01	39.04
Debt / Equity Ratio	0.71	0.75	0.76	0.84	0.85	1.45
Debt / EBITDA Ratio	1.57	1.70	2.04	2.23	4.81	3.15
Debt / FCF Ratio	2.58	3.07	3.30	3.57	6.85	5.92
Asset Turnover	0.53	0.53	0.46	0.44	0.44	0.42
Inventory Turnover	1.59	1.80	1.59	1.26	1.85	1.45
Quick Ratio	0.69	0.67	0.58	0.62	0.67	0.67
Current Ratio	0.88	0.93	0.82	0.86	1.16	0.96
Return on Equity (ROE)	21.67%	17.59%	15.64%	8.63%	0.42%	20.80%
Return on Assets (ROA)	9.07%	7.88%	6.10%	5.46%	2.10%	4.26%
Return on Capital (ROIC)	13.17%	11.53%	8.80%	7.82%	3.26%	7.45%
Return on Capital Employed (ROCE)	19.80%	17.00%	13.70%	12.60%	3.50%	9.40%
Earnings Yield	3.50%	3.46%	2.85%	1.57%	0.06%	2.44%
FCF Yield	4.71%	4.89%	4.29%	4.16%	2.68%	2.92%
Dividend Yield	1.07%	4.83%	4.50%	4.58%	5.36%	6.38%
Payout Ratio	52.89%	65.80%	75.25%	132.72%	3442.86%	111.77%
Buyback Yield / Dilution	0.08%	-0.06%	-0.13%	-9.32%	-8.68%	-0.92%
Total Shareholder Return	1.15%	4.76%	4.37%	-4.74%	-3.32%	5.46%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.